JP2022528570A5 - - Google Patents

Info

Publication number
JP2022528570A5
JP2022528570A5 JP2021560695A JP2021560695A JP2022528570A5 JP 2022528570 A5 JP2022528570 A5 JP 2022528570A5 JP 2021560695 A JP2021560695 A JP 2021560695A JP 2021560695 A JP2021560695 A JP 2021560695A JP 2022528570 A5 JP2022528570 A5 JP 2022528570A5
Authority
JP
Japan
Application number
JP2021560695A
Other languages
Japanese (ja)
Other versions
JPWO2020208201A5 (https=
JP7620565B2 (ja
JP2022528570A (ja
Filing date
Publication date
Priority claimed from EP19168673.2A external-priority patent/EP3721870A1/de
Application filed filed Critical
Publication of JP2022528570A publication Critical patent/JP2022528570A/ja
Publication of JPWO2020208201A5 publication Critical patent/JPWO2020208201A5/ja
Publication of JP2022528570A5 publication Critical patent/JP2022528570A5/ja
Application granted granted Critical
Publication of JP7620565B2 publication Critical patent/JP7620565B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021560695A 2019-04-11 2020-04-09 有効成分顆粒の連続製造のためのプロセス Active JP7620565B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19168673.2A EP3721870A1 (de) 2019-04-11 2019-04-11 Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats
EP19168673.2 2019-04-11
PCT/EP2020/060277 WO2020208201A1 (de) 2019-04-11 2020-04-09 Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats

Publications (4)

Publication Number Publication Date
JP2022528570A JP2022528570A (ja) 2022-06-14
JPWO2020208201A5 JPWO2020208201A5 (https=) 2023-04-14
JP2022528570A5 true JP2022528570A5 (https=) 2023-04-14
JP7620565B2 JP7620565B2 (ja) 2025-01-23

Family

ID=66105201

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021560695A Active JP7620565B2 (ja) 2019-04-11 2020-04-09 有効成分顆粒の連続製造のためのプロセス

Country Status (10)

Country Link
US (1) US20220323361A1 (https=)
EP (2) EP3721870A1 (https=)
JP (1) JP7620565B2 (https=)
CN (1) CN114126591A (https=)
AU (1) AU2020272151B2 (https=)
BR (1) BR112021020320A2 (https=)
CA (1) CA3136529A1 (https=)
ES (1) ES3050631T3 (https=)
IL (1) IL287126B1 (https=)
WO (1) WO2020208201A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3721871A1 (de) * 2019-04-11 2020-10-14 ADD Advanced Drug Delivery Technologies, Ltd. Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats
MX2023006016A (es) * 2020-11-24 2023-08-14 Nanoform Finland PLC Sistema, aparatos, dispositivos y metodos para producir particulas.
CN116422227B (zh) * 2022-12-09 2024-01-30 山东奥诺能源科技股份有限公司 一种流化床造粒机

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19514187C1 (de) * 1995-04-21 1996-05-15 Degussa Verfahren und Vorrichtung zur Herstellung von Granulaten durch Wirbelschicht-Sprühgranulation
US6117451A (en) 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
DE10004939C1 (de) 2000-02-05 2001-08-23 Lothar Moerl Steuerbare Gasanströmeinrichtung für Strahlschichtapparate
ES2260345T3 (es) * 2001-03-07 2006-11-01 Dainippon Sumitomo Pharma Co., Ltd. Metodo para fabricar granulos de farmacos, los granulos de farmaco y preparacion farmaceutica que contiene los granulos de farmaco.
US6667054B2 (en) 2001-12-05 2003-12-23 Bernard Charles Sherman Metformin hydrochloride tablets
DE10322062A1 (de) 2003-05-15 2004-12-02 Glatt Ingenieurtechnik Gmbh Verfahren und Vorrichtung zum Aufbringen von Flüssigkeiten in eine Feststoffströmung eines Strahlschichtapparates
ES2374191T3 (es) 2003-06-11 2012-02-14 Glatt Ingenieurtechnik Gmbh Procedimiento de preparación de granulados de enzimas y granulados de enzimas así obtenidos.
CA2572549A1 (en) * 2004-07-01 2006-01-12 Warner-Lambert Company Llc Preparation of pharmaceutical compositions containing nanoparticles
DE102007012105A1 (de) * 2007-03-13 2008-09-18 Add Advanced Drug Delivery Technologies Ltd. Pellets enthaltend pharmazeutische Substanz, Verfahren zu deren Herstellung und deren Verwendung
EP2590631B1 (en) * 2010-07-06 2016-10-26 Janssen Pharmaceutica NV Formulation for co-therapy treatment of diabetes
WO2013143688A1 (en) * 2012-03-26 2013-10-03 Glatt Ag Taste-masked ibuprofen granules
JP5922310B2 (ja) * 2013-07-25 2016-05-24 株式会社三和化学研究所 医薬製剤
KR101642193B1 (ko) * 2014-10-13 2016-07-25 씨제이헬스케어 주식회사 메트포르민 서방성 제제 및 그의 제조방법
WO2018034627A1 (en) * 2016-08-18 2018-02-22 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Pharmaceutical composition of antidiabetic tablet

Similar Documents

Publication Publication Date Title
JP2022528570A5 (https=)
BR202021014609U2 (https=)
CN305764060S (https=)
CN305531733S (https=)
CN305756898S (https=)
CN305534793S (https=)
CN305534640S (https=)
CN305534117S (https=)
CN305533552S (https=)
CN305533345S (https=)
CN305532289S (https=)
CN305759507S (https=)
CN305982572S (https=)
CN305536475S (https=)
CN305766864S (https=)
CN305974619S (https=)
CN306050976S (https=)
CN305765939S (https=)
CN306049679S (https=)
CN306047776S (https=)
CN306047304S (https=)
CN305986998S (https=)
CN305985802S (https=)
CN305985151S (https=)
CN305534896S (https=)